ID   DGLB_RAT                Reviewed;         668 AA.
AC   P0C1S9;
DT   05-SEP-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-SEP-2006, sequence version 1.
DT   24-JUL-2024, entry version 103.
DE   RecName: Full=Diacylglycerol lipase-beta;
DE            Short=DAGL-beta;
DE            Short=DGL-beta {ECO:0000303|PubMed:16051747};
DE            EC=3.1.1.116 {ECO:0000250|UniProtKB:Q8NCG7};
DE   AltName: Full=PUFA-specific triacylglycerol lipase;
DE            EC=3.1.1.3 {ECO:0000250|UniProtKB:Q91WC9};
DE   AltName: Full=Sn1-specific diacylglycerol lipase beta;
GN   Name=Daglb;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=16051747; DOI=10.1124/mol.105.013961;
RA   Jung K.-M., Mangieri R., Stapleton C., Kim J., Fegley D., Wallace M.,
RA   Mackie K., Piomelli D.;
RT   "Stimulation of endocannabinoid formation in brain slice cultures through
RT   activation of group I metabotropic glutamate receptors.";
RL   Mol. Pharmacol. 68:1196-1202(2005).
CC   -!- FUNCTION: Lipase that catalyzes the hydrolysis of arachidonic acid
CC       (AA)-esterified diacylglycerols (DAGs) to produce the principal
CC       endocannabinoid, 2-arachidonoylglycerol (2-AG) which can be further
CC       cleaved by downstream enzymes to release arachidonic acid (AA) for
CC       cyclooxygenase (COX)-mediated eicosanoid production. Preferentially
CC       hydrolyzes DAGs at the sn-1 position in a calcium-dependent manner and
CC       has negligible activity against other lipids including
CC       monoacylglycerols and phospholipids (By similarity). Plays a key role
CC       in the regulation of 2-AG and AA pools utilized by COX1/2 to generate
CC       lipid mediators of macrophage and microglia inflammatory responses.
CC       Functions also as a polyunsaturated fatty acids-specific
CC       triacylglycerol lipase in macrophages. Plays an important role to
CC       support the metabolic and signaling demands of macrophages (By
CC       similarity). {ECO:0000250|UniProtKB:Q8NCG7,
CC       ECO:0000250|UniProtKB:Q91WC9}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycerol + H2O = a 2-acylglycerol + a fatty
CC         acid + H(+); Xref=Rhea:RHEA:33275, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17389, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:28868; EC=3.1.1.116;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33276;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycerol
CC         + H2O = 2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H(+) +
CC         octadecanoate; Xref=Rhea:RHEA:38507, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:52392,
CC         ChEBI:CHEBI:75728; Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38508;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-di-(9Z-octadecenoyl)-sn-glycerol + H2O = (9Z)-
CC         octadecenoate + 2-(9Z-octadecenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:38511, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:52333, ChEBI:CHEBI:73990;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38512;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-
CC         glycerol + H2O = (9Z)-octadecenoate + 2-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-glycerol + H(+); Xref=Rhea:RHEA:38515,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:52392, ChEBI:CHEBI:75449;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38516;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycerol + H2O = (9Z)-
CC         octadecenoate + 2-octadecanoylglycerol + H(+); Xref=Rhea:RHEA:38519,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75448, ChEBI:CHEBI:75456;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38520;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-(9Z,12Z-octadecadienoyl)-sn-glycerol +
CC         H2O = (9Z)-octadecenoate + 2-(9Z,12Z-octadecadienoyl)-glycerol +
CC         H(+); Xref=Rhea:RHEA:38523, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30823, ChEBI:CHEBI:75450, ChEBI:CHEBI:75457;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38524;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-2-O-(5Z,8Z,11Z,14Z-eicosatetraenyl)-sn-
CC         glycerol + H2O = (9Z)-octadecenoate + 2-O-(5Z,8Z,11Z,14Z)-
CC         eicosatetraenylglycerol + H(+); Xref=Rhea:RHEA:38527,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30823,
CC         ChEBI:CHEBI:75913, ChEBI:CHEBI:75914;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38528;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a triacylglycerol + H2O = a diacylglycerol + a fatty acid +
CC         H(+); Xref=Rhea:RHEA:12044, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17855, ChEBI:CHEBI:18035, ChEBI:CHEBI:28868; EC=3.1.1.3;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12045;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-tri-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H2O =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoate + 1,2-di-(5Z,8Z,11Z,14Z-
CC         eicosatetraenoyl)-glycerol + H(+); Xref=Rhea:RHEA:63432,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:32395,
CC         ChEBI:CHEBI:147308, ChEBI:CHEBI:228166;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63433;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2,3-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycerol + H2O =
CC         (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate + 1,2-di-
CC         (4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-glycerol + H(+);
CC         Xref=Rhea:RHEA:63436, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:77016, ChEBI:CHEBI:147311, ChEBI:CHEBI:228170;
CC         Evidence={ECO:0000250|UniProtKB:Q91WC9};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000250|UniProtKB:Q8NCG7};
CC   -!- ACTIVITY REGULATION: Inhibited by the 1,2,3-triazole urea covalent
CC       inhibitors KT109 and KT172 (By similarity). Inhibited by p-hydroxy-
CC       mercuri-benzoate and HgCl(2), but not by PMSF. Also inhibited by
CC       RHC80267, a drug that blocks 2-AG formation (By similarity).
CC       {ECO:0000250|UniProtKB:Q8NCG7, ECO:0000250|UniProtKB:Q91WC9}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q8NCG7};
CC       Multi-pass membrane protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed in corticostriatal and hippocampal
CC       slices. Highly expressed in striatal neurons (at protein level).
CC       {ECO:0000269|PubMed:16051747}.
CC   -!- SIMILARITY: Belongs to the AB hydrolase superfamily. Lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03083354; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03082268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03083835; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03083932; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03084256; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03083962; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03083512; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   AlphaFoldDB; P0C1S9; -.
DR   SMR; P0C1S9; -.
DR   STRING; 10116.ENSRNOP00000062663; -.
DR   ESTHER; rat-dglb; Lipase_3.
DR   iPTMnet; P0C1S9; -.
DR   PhosphoSitePlus; P0C1S9; -.
DR   SwissPalm; P0C1S9; -.
DR   jPOST; P0C1S9; -.
DR   PaxDb; 10116-ENSRNOP00000062663; -.
DR   AGR; RGD:1310193; -.
DR   RGD; 1310193; Daglb.
DR   eggNOG; KOG2088; Eukaryota.
DR   InParanoid; P0C1S9; -.
DR   PhylomeDB; P0C1S9; -.
DR   TreeFam; TF312928; -.
DR   Reactome; R-RNO-426048; Arachidonate production from DAG.
DR   PRO; PR:P0C1S9; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001079; Expressed in spleen and 18 other cell types or tissues.
DR   ExpressionAtlas; P0C1S9; baseline and differential.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0047372; F:acylglycerol lipase activity; ISO:RGD.
DR   GO; GO:0016298; F:lipase activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004806; F:triglyceride lipase activity; ISS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:1901696; P:cannabinoid biosynthetic process; ISO:RGD.
DR   GO; GO:0046340; P:diacylglycerol catabolic process; IBA:GO_Central.
DR   GO; GO:0006690; P:icosanoid metabolic process; ISS:UniProtKB.
DR   GO; GO:0006640; P:monoacylglycerol biosynthetic process; ISO:RGD.
DR   GO; GO:0007405; P:neuroblast proliferation; ISO:RGD.
DR   GO; GO:0022008; P:neurogenesis; ISO:RGD.
DR   GO; GO:0010898; P:positive regulation of triglyceride catabolic process; ISS:UniProtKB.
DR   GO; GO:0001516; P:prostaglandin biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0050727; P:regulation of inflammatory response; ISS:UniProtKB.
DR   CDD; cd00519; Lipase_3; 1.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR052214; DAG_Lipase-Related.
DR   InterPro; IPR002921; Fungal_lipase-like.
DR   PANTHER; PTHR45792; DIACYLGLYCEROL LIPASE HOMOLOG-RELATED; 1.
DR   PANTHER; PTHR45792:SF2; DIACYLGLYCEROL LIPASE-BETA; 1.
DR   Pfam; PF01764; Lipase_3; 1.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
DR   PROSITE; PS00120; LIPASE_SER; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Metal-binding; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..668
FT                   /note="Diacylglycerol lipase-beta"
FT                   /id="PRO_0000248352"
FT   TOPO_DOM        1..17
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        18..38
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        39..58
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        59..79
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        80..102
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        103..123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        124..128
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        129..149
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        150..668
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        443
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NCG7"
FT   ACT_SITE        495
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NCG7"
FT   MOD_RES         570
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NCG7"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NCG7"
FT   MOD_RES         582
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91WC9"
SQ   SEQUENCE   668 AA;  73771 MW;  B47999973A10E7EF CRC64;
     MPGMVLFGRR WSLASDDLVF PGSFELFLRV LWWIASLTLY LMHRRKLDCP GGVLLSTYLI
     VLLVLLAVII GIVLAIVCVS MRGTICNPGP RKSMSKLLYI RLALFLPEMV WASLGAAWVA
     KGIQCDRTVV IGIIATVIVS WIVIAATMVT IVFVFDPLGG KMAPYPPCIP EHLDSNSSNH
     LLTGLRTAAK SVWETRVQCC CCCIGQDDNT RVAFSSTADL FSTYFSDTDL VPSDIAAGFT
     LLHQQQDKIS HSREPSEVVT HTPGQPQETE LDAEVENCHH YMPFSPVCSP WPVCVLNSSR
     VELCRTGNNF CRGRDIEYDA VEGDEHHCHF ASILKTTGLQ YRDFIHVSFH DKVYELPFIV
     VLDHRKESVV VAVRGTMSLQ DVLTDLSAES ENLELDIELQ DCVAHKGIAQ AARYIYRRLV
     NDGILSQAFS VAPEYRLVVV GHSLGAGAAA LLAIMLRGAY PQVRAYAFSP PRGLLSKSLF
     EYSKDFVVSL ILGMDVIPRL SVANMEDLKR RILRVIANCN KPKYKILLHG CWYSVFGGSP
     DNFPTELDEG NQGALTQPLL GEQTLLTRCS PGYCSGDSPL DSPKYPTLYP PGRIIHLEEE
     GGSGRFGCCS AAQYRARWAH ETEFSKILIG PKMLIDHMPD VMIRALDRVV ADRTACVSCP
     GQGGSNVP
//
